Frederick Kluge

Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis

S. Mustjoki, T. Brümmendorf, J. Panse, 2020, bioRxiv.

CRISPR/Cas9-engineered human ES cells harboring heterozygous and homozygous c-KIT knockout.

T. Brümmendorf, M. Zenke, M. A. D. de Toledo, 2022, Stem cell research.